Item 1.01 Entry into a Material Definitive Agreement.
On
The Offering was made pursuant to the Company's effective shelf registration
statement on Form S-3ASR (File No. 333-236489), including the prospectus dated
In the Underwriting Agreement, the Company makes customary representations,
warranties and covenants and also agrees to indemnify the Underwriters against
certain liabilities, including liabilities under the Securities Act of 1933, as
amended, or to contribute to payments that the Underwriters may be required to
make because of such liabilities. The foregoing is only a brief description of
the terms of the Underwriting Agreement, does not purport to be a complete
description of the rights and obligations of the parties thereunder, and is
qualified in its entirety by reference to the Underwriting Agreement that is
filed as Exhibit 1.1 to this Current Report on Form 8-K and incorporated by
reference herein. The legal opinion of
Item 8.01 Other Events.
On
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 1.1 Underwriting Agreement, dated as ofMay 18, 2020 , among bluebird bio, Inc. andGoldman Sachs & Co. LLC ,BofA Securities, Inc. andCowen and Company, LLC , as representatives of the underwriters named therein. 5.1 Opinion ofGoodwin Procter LLP . 23.1 Consent ofGoodwin Procter LLP (included in Exhibit 5.1). 99.1 Press release issued by bluebird bio, Inc. onMay 18, 2020 . 99.2 Press release issued by bluebird bio, Inc. onMay 18, 2020 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source